US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SIMPLIFY MANAGED FUTURES STRATEGY ETF

27.89

-0.6600-2.31%

Post-market: 27.890.00000.00%19:30 EDT

Volume:320.68K

Turnover:8.96M

Market Cap:1.60B

PE:- -

High:28.42

Open:28.42

Low:27.82

Close:28.55

52wk High:32.76

52wk Low:25.39

Shares:57.38M

Float Shares:57.38M

Volume Ratio:0.93

T/O Rate:0.56%

Dividend:1.39

Dividend Rate:4.99%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Ribo Announces Phase 2 Clinical Trial Submission to EMA, Further Advancing siRNA Therapeutics in Thromboembolic Disease

Hisense เปิดตัว UR8 ด้วยสีสันที่เป็นธรรมชาติและสมจริง นำเทคโนโลยี RGB MiniLED รุ่นใหม่สู่ครอบครัว

Hisense Perkenal UR8 dengan Warna Semula Jadi dan Realistik, Bawa Teknologi RGB MiniLED Generasi Baharu ke Lebih Banyak Kediaman

Propanc Biopharma’s CEO Forecasts New Medical Breakthroughs in the Fight Against Pancreatic Cancer Over the Next Decade

Global Long-Term Bond Yields Soar, Pressuring Equity Markets; Silver Gains 2%

U.S. Treasury Bulls Capitulate En Masse as CTA, Asset Managers, and Japanese Investors Retreat, Signaling Potential Greater Turmoil Ahead

U.S. Treasury Bond Bulls Capitulate: CTAs, Asset Managers, and Japanese Investors Simultaneously Retreat, Signaling Potential Turmoil Ahead

Polyrizon Advances Towards Human Clinical Trials: Secures First U.S. Clinical Site for NASARIX™ Allergy Blocker Clinical Trial

ProQR Announces First Quarter 2026 Operating and Financial Results

Gold overtakes dollar reserves as global trust shifts

Press Release: Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates

Press Release: Entrada Therapeutics Reports First Quarter 2026 Financial Results

Immunocore reports first quarter financial results and provides a business update

Strategy Shares Down 1.1% Premarket After Co Posts Wider Quarterly Loss

THOMSON REUTERS

Goldman Sachs Warns of Market Pullback Ahead of Tech Giants' Earnings Reports

Oil Price Pressures May Linger Longer Than Expected, Goldman Warns: CTA Ammunition Depleted, Equity Downside Risks Accumulating

Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update

Hisense Memperkenalkan UR9 Series, Mendefinisikan Era Baharu Paparan RGB MiniLED Sebenar

Enlivex receives CTA approval by DKMA for Phase 2b trial of Allocetra

Enlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/CTA/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CTA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTA\",,,,,undefined,":{"symbol":"CTA","market":"US","secType":"STK","nameCN":"SIMPLIFY MANAGED FUTURES STRATEGY ETF","latestPrice":27.89,"timestamp":1787601600000,"preClose":28.55,"halted":0,"volume":320679,"hourTrading":{"tag":"盘后","latestPrice":27.89,"preClose":27.89,"latestTime":"19:30 EDT","volume":537,"amount":14978.03,"timestamp":1787614204731,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.02311733800350263,"floatShares":57375001,"shares":57375001,"eps":0,"marketStatus":"Closed","change":-0.66,"latestTime":"08-24 16:00:00 EDT","open":28.42,"high":28.42,"low":27.8201,"amount":8963144.161721999,"amplitude":0.021012,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":5,"adr":0,"exchange":"ARCA","adjPreClose":28.55,"sharesOutstanding":45800001,"nav":28.6674,"aum":1629261398.01,"dividendRate":0.049946,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":28.33,"preClose":28.55,"latestTime":"09:29 EDT","volume":16,"amount":453.5,"timestamp":1787578195071,"change":-0.22,"changeRate":-0.007706,"amplitude":0.007706},"postHourTrading":{"tag":"盘后","latestPrice":27.89,"preClose":27.89,"latestTime":"19:30 EDT","volume":537,"amount":14978.03,"timestamp":1787614204731,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.933442,"impliedVol":0.0888,"impliedVolPercentile":0.3625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTA\",,,,,undefined,":{"symbol":"CTA","floatShares":57375001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.933442,"shares":57375001,"dividePrice":1.393,"high":28.42,"amplitude":0.021012,"preClose":28.55,"low":27.8201,"week52Low":25.39,"pbRate":"--","week52High":32.76,"institutionHeld":0,"latestPrice":27.89,"eps":0,"divideRate":0.049946,"volume":320679,"delay":0,"ttmEps":0,"open":28.42,"prevYearClose":27.26,"prevWeekClose":28.55,"prevMonthClose":27.14,"prevQuarterClose":25.94,"fiveDayClose":27.88,"twentyDayClose":26.79,"sixtyDayClose":29.13},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CTA\",params:#limit:5,,,undefined,":[{"date":"2026-07-28","symbol":"CTA","amount":0.13,"announcedDate":"2026-07-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-28","defaultRemindTime":1785245400000,"name":"SIMPLIFY MANAGED FUTURES STRATEGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-31","payableDate":"2026-07-28","currency":"USD","dateTimestamp":1785211200000,"payDate":"2026-07-31"},{"date":"2026-06-25","symbol":"CTA","amount":0.13,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"SIMPLIFY MANAGED FUTURES STRATEGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"},{"date":"2026-05-26","symbol":"CTA","amount":0.15,"announcedDate":"2026-05-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-26","defaultRemindTime":1779802200000,"name":"SIMPLIFY MANAGED FUTURES STRATEGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-29","payableDate":"2026-05-26","currency":"USD","dateTimestamp":1779768000000,"payDate":"2026-05-29"},{"date":"2026-04-27","symbol":"CTA","amount":0.15,"announcedDate":"2026-04-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-27","defaultRemindTime":1777296600000,"name":"SIMPLIFY MANAGED FUTURES STRATEGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-30","payableDate":"2026-04-27","currency":"USD","dateTimestamp":1777262400000,"payDate":"2026-04-30"},{"date":"2026-03-26","symbol":"CTA","amount":0.15,"announcedDate":"2026-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-26","defaultRemindTime":1774531800000,"name":"SIMPLIFY MANAGED FUTURES STRATEGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-26","currency":"USD","dateTimestamp":1774497600000,"payDate":"2026-03-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CTA\",market:\"US\",,,undefined,":[{"executeDate":"2022-08-26","recordDate":"2022-08-29","paymentDate":"2022-08-31","value":0.15,"currency":"USD"},{"executeDate":"2022-09-27","recordDate":"2022-09-28","paymentDate":"2022-09-30","value":0.15,"currency":"USD"},{"executeDate":"2022-10-26","recordDate":"2022-10-27","paymentDate":"2022-10-31","value":0.15,"currency":"USD"},{"executeDate":"2022-11-25","recordDate":"2022-11-28","paymentDate":"2022-11-30","value":0.15,"currency":"USD"},{"executeDate":"2022-12-27","recordDate":"2022-12-28","paymentDate":"2022-12-30","value":1.11096,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CTA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CTA\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2638656566","title":"Ribo Announces Phase 2 Clinical Trial Submission to EMA, Further Advancing siRNA Therapeutics in Thromboembolic Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2638656566","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638656566?lang=en_us&edition=fundamental","pubTime":"2026-05-28 10:43","pubTimestamp":1779936180,"startTime":"0","endTime":"0","summary":"Coronary artery disease  remains a leading cause of morbidity and mortality globally, driven by atherosclerotic plaque formation and associated thrombotic complications such as myocardial infarction and other ischemic events. Despite the widespread use of standard of care therapies, including antiplatelet and anticoagulant therapies, a substantial residual risk of thrombotic events remains in patients with stable CAD, even when treated with optimized treatment. Current therapies are further limited by an increased risk of bleeding, restricting their intensity and long-term use in many patients. Consequently, there is a significant unmet medical need for novel antithrombotic approaches that can provide effective and sustained protection against thrombosis while maintaining a favorable safety profile, particularly with respect to bleeding risk.\"We are very pleased to advance our anti-thrombotic siRNA programs into the next stage of clinical development in Europe. This milestone reflects ","market":"other","thumbnail":"https://mma.prnewswire.com/media/2804420/logo_Ribolia_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2804420/logo_Ribolia_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/ribo-announces-phase-2-clinical-trial-submission-to-ema-further-advancing-sirna-therapeutics-in-thromboembolic-disease-302783857.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7095","BK4007","EMA.AU","CAD.AU","LENZ","EMA","BK4139","BK4081","CTA","BK7129","BK4539","BK7504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637908523","title":"Hisense เปิดตัว UR8 ด้วยสีสันที่เป็นธรรมชาติและสมจริง นำเทคโนโลยี RGB MiniLED รุ่นใหม่สู่ครอบครัว","url":"https://stock-news.laohu8.com/highlight/detail?id=2637908523","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637908523?lang=en_us&edition=fundamental","pubTime":"2026-05-22 17:00","pubTimestamp":1779440400,"startTime":"0","endTime":"0","summary":", ,22  2569 /PRNewswire/ -- Hisense   UR8  RGB MiniLED. RGB MiniLED Hisense  RGB MiniLED   Chromagic  Hisense  Chromagic RGB     UR8   BT.2020 100%      \"RGB LED\"   Hisense   RGB MiniLED. UR8  Hi-View AI Engine RGB     180Hz     2.1.2  Devialet. Hisense  RGB MiniLED  UR8     UR8  HisenseHisense 2512 160    OmdiaHisense1100 RGB MiniLEDHisenseRGB MiniLED FIFA Club World Cup 2026SOURCE Hisense","market":"other","thumbnail":"https://mma.prnewswire.com/media/2982963/UR8_18x9_TR.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2982963/UR8_18x9_TR.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/hisense--ur8---rgb-miniled--302776252.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637901893","title":"Hisense Perkenal UR8 dengan Warna Semula Jadi dan Realistik, Bawa Teknologi RGB MiniLED Generasi Baharu ke Lebih Banyak Kediaman","url":"https://stock-news.laohu8.com/highlight/detail?id=2637901893","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637901893?lang=en_us&edition=fundamental","pubTime":"2026-05-22 17:00","pubTimestamp":1779440400,"startTime":"0","endTime":"0","summary":"QINGDAO, China, 22 Mei 2026 /PRNewswire/ -- Hisense, jenama terkemuka global dalam elektronik pengguna dan perkakas rumah, hari ini memperkenalkan UR8, siri TV RGB MiniLED mampu milik yang direka untuk membawa teknologi paparan generasi baharu, warna semula jadi dan realistik, hiburan imersif serta prestasi permainan video termaju kepada lebih ramai pengguna di seluruh dunia.Menerusi UR8, Hisense terus mempercepat penggunaan teknologi RGB MiniLED, sekali gus menjadikan inovasi paparan generasi baharu lebih mudah diakses pengguna global. Menggabungkan prestasi imej termaju, pemprosesan pintar dan reka bentuk sofistikated, UR8 mewakili satu lagi langkah besar ke hadapan dalam masa depan hiburan rumah premium.Latar Belakang HisenseDitubuhkan pada tahun 1969, Hisense merupakan peneraju global yang diiktiraf dalam bidang perkakas rumah dan elektronik pengguna dengan operasi di lebih 160 negara, khusus dalam penyediaan produk multimedia berkualiti tinggi, perkakas rumah dan penyelesaian IT p","market":"hk","thumbnail":"https://mma.prnewswire.com/media/2982962/UR8_18x9_TR.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2982962/UR8_18x9_TR.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/hisense-perkenal-ur8-dengan-warna-semula-jadi-dan-realistik-bawa-teknologi-rgb-miniled-generasi-baharu-ke-lebih-banyak-kediaman-302776135.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636840428","title":"Propanc Biopharma’s CEO Forecasts New Medical Breakthroughs in the Fight Against Pancreatic Cancer Over the Next Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2636840428","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636840428?lang=en_us&edition=fundamental","pubTime":"2026-05-20 20:45","pubTimestamp":1779281100,"startTime":"0","endTime":"0","summary":"Plans to File CTA for Ph. 1b, FIH Study, 30 – 40 Advanced Cancer Patients in ‘26MELBOURNE, Australia, May  20, 2026  (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Compa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/20/3298501/0/en/Propanc-Biopharma-s-CEO-Forecasts-New-Medical-Breakthroughs-in-the-Fight-Against-Pancreatic-Cancer-Over-the-Next-Decade.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165357663","title":"Global Long-Term Bond Yields Soar, Pressuring Equity Markets; Silver Gains 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1165357663","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165357663?lang=en_us&edition=fundamental","pubTime":"2026-05-20 15:37","pubTimestamp":1779262639,"startTime":"0","endTime":"0","summary":"As inflation expectations rise following the Iran conflict, bond yields have surged significantly. The deep divergence between stock and bond markets has prompted multiple institutions to issue...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UDN","UUP","DUG","CTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157043430","title":"U.S. Treasury Bulls Capitulate En Masse as CTA, Asset Managers, and Japanese Investors Retreat, Signaling Potential Greater Turmoil Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=1157043430","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157043430?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:16","pubTimestamp":1779192981,"startTime":"0","endTime":"0","summary":"The U.S. Treasury market is witnessing a broad capitulation among bullish investors. According to Bank of America's latest research report on May 19, long positions across the Treasury yield curve...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GBIL","BK4535","IEF","USHY","VCSH","TLTI","TBIL","SHY","TIP","TLTX","BK4581","BOXX","GOVT","SGOV","TFJL","EDV","CTA","BK4561","DBND","MTNmain","IEI","BBSB","BK4550","UBT","ZFmain","SHV","VGSH","VGLT","BK4588","HYG","FLGV","TMF","TBJL","LQD","TSYW","VCIT","AGG","NGHT","BOND","BIL","SCHO","BWZ","BITC","UBmain","BBLB","ZTmain","BNDW","UFIV","UTRE","TLTW","BK4585","TNmain","BK4504","TLH","ISHG","ZNmain","ZROZ","UTHY","TBT","TLT","MUB","BND","BWX","ZBmain","JPST","MINT","UTWY","GOLY","MWNmain","IGOV","TYO","BSV","BBIB","USVN","VGIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121286287","title":"U.S. Treasury Bond Bulls Capitulate: CTAs, Asset Managers, and Japanese Investors Simultaneously Retreat, Signaling Potential Turmoil Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=1121286287","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121286287?lang=en_us&edition=fundamental","pubTime":"2026-05-19 16:03","pubTimestamp":1779177834,"startTime":"0","endTime":"0","summary":"The U.S. Treasury market is witnessing a rare capitulation among bullish investors. On May 19, according to reports from trading desks, Bank of America Merrill Lynch's latest research indicates that...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSV","BK4535","UTWY","TLH","BBIB","BNDW","IGOV","GOVT","DBND","UBT","VGIT","BK4588","JPST","BWZ","AGG","TYO","USVN","GOLY","MINT","NGHT","SHY","ZROZ","BIL","TLTI","TIP","TMF","SCHO","UFIV","USHY","BOXX","BND","TBJL","BK4550","BK4581","CTA","MUB","TLT","TLTX","BK4561","UTRE","LQD","TLTW","VGSH","BK4585","UTHY","TBT","TNmain","GBIL","BOND","SHV","EDV","ZFmain","IEI","VCIT","BWX","TFJL","MWNmain","BITC","BK4504","UBmain","ZBmain","ZTmain","BBLB","ISHG","TSYW","TBIL","VCSH","SGOV","FLGV","ZNmain","IEF","MTNmain","HYG","BBSB","VGLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635780133","title":"Polyrizon Advances Towards Human Clinical Trials: Secures First U.S. Clinical Site for NASARIX™ Allergy Blocker Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2635780133","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635780133?lang=en_us&edition=fundamental","pubTime":"2026-05-13 21:25","pubTimestamp":1778678700,"startTime":"0","endTime":"0","summary":"Raanana, Israel, May  13, 2026  (GLOBE NEWSWIRE) --  Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative int","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/13/3294087/0/en/Polyrizon-Advances-Towards-Human-Clinical-Trials-Secures-First-U-S-Clinical-Site-for-NASARIX-Allergy-Blocker-Clinical-Trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634137322","title":"ProQR Announces First Quarter 2026 Operating and Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2634137322","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634137322?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:00","pubTimestamp":1778583600,"startTime":"0","endTime":"0","summary":"AX-0810 target engagement data in healthy volunteers on track for Q2 2026; biliary atresia selected as initial Phase 2 indicationPipeline expansion with advancement of AX-0811 (NTCP) and AX-0422 (IDUA","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/12/3292670/33039/en/ProQR-Announces-First-Quarter-2026-Operating-and-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4567","BOED","A","LU1435385759.SGD","LU1429558221.USD","BK4588","LU2413666699.HKD","IE00BN0W2W23.USD","LU1166156734.SGD","LU2413666426.HKD","BK4516","IE00BN0W2T93.GBP","BK4187","BK4226","LU1165135440.EUR","LU0702159699.USD","G","IE00BN0W2V16.EUR","LU0347712357.USD","RNA","BOEU","BK4551","LU2092937221.SGD","BOEG","LU2041044095.USD","CTA","BK4523","LU1543694498.USD","LU2229751404.USD","BK4505","LU2326559502.SGD","IE0009354923.USD","BK4106","IE000M9KFDE8.USD","BK4139","BA","BK4564","BK4121","LU2089279066.USD","BK4585","LU1721428933.USD","LU0702159343.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634253293","title":"Gold overtakes dollar reserves as global trust shifts","url":"https://stock-news.laohu8.com/highlight/detail?id=2634253293","media":"Kitco","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634253293?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:54","pubTimestamp":1778500440,"startTime":"0","endTime":"0","summary":"Key TakeawaysGold Reclaims Monetary Leadership: Gold has overtaken U.S. dollar reserves globally, reinforcing its role as the primary neutral reserve asset amid eroding confidence in the dollar system","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"kitco_highlight","url":"https://www.kitco.com/opinion/2026-05-11/gold-overtakes-dollar-reserves-global-trust-shifts","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.kitco.com/opinion/2026-05-11/gold-overtakes-dollar-reserves-global-trust-shifts","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"kitco_highlight","symbols":["SGCmain","RMP","JDST","DGP","CEF","GDXD","GBUG","GDXU","BEGS","BAR","SHNY","1OZmain","AAAU","GDXY","SGDM","DBC","OUNZ","USG","UGL","GCmain","GDP","CTA","IAUM","IAUI","AGQ","MGCmain","RING","UDN","XME","PICK","GLL","GDX","GOLY","PHYS","DZZ","UUP","GDXJ","BTGD","FGDL","GLDM","GOAU","GLTR","DULL","159934","IAU","UYM","JNUG","SGOL","UAE","DUST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633144834","title":"Press Release: Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2633144834","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633144834?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:00","pubTimestamp":1778155200,"startTime":"0","endTime":"0","summary":"-- On track to file IND and/or CTA for PM577 in Wilson. Disease in H1 2026 and for PM647 in AATD mid-2026;-- Continued regulatory dialogue with the FDA toward. cash of $149.2 million as of March 31, 2026, providing. Prime Medicine is currently advancing in vivo programs to cure two of the largest genetic liver diseases, Wilson Disease  and Alpha-1 Antitrypsin Deficiency . Prime Medicine expects to file an Investigational New Drug application  and/or Clinical Trial Application  for PM577 in WD in the first half of 2026 and for PM647 in AATD in mid-2026; initial clinical data from both programs are expected in 2027.Prime Medicine is also advancing an in vivo Cystic Fibrosis  program with support from the Cystic Fibrosis Foundation, and efforts to develop Prime Edited CAR-T products for hematology, immunology and oncology in partnership with Bristol Myers Squibb. Additionally, following positive proof-of-concept data from the first two patients treated in its Phase 1/2 study of PM359 for ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IND","BK4195","BK4229","BK4093","WD","CF","CTA","BK4139","PRME","BK4585","CFO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633146327","title":"Press Release: Entrada Therapeutics Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633146327","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633146327?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:10","pubTimestamp":1778152200,"startTime":"0","endTime":"0","summary":"-- Announced positive ELEVATE-44-201 Cohort 1 topline results in Duchenne muscular dystrophy showing favorable safety, tolerability and early functional benefit --. -- Company on track to report ELEVATE-45-201 Cohort 1 data in mid-2026, as well as ELEVATE-44-201 open-label period and Cohort 2 data by year-end 2026 --. -- Cash runway expected into Q3 2027 with $255 million in cash, cash equivalents and marketable securities as of March 31, 2026 --. BOSTON, May 07, 2026  -- Entrada Therapeutics, Inc.  today reported financial results for the first quarter ended March 31, 2026, and highlighted recent business updates.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CTA","TRDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633182528","title":"Immunocore reports first quarter financial results and provides a business update","url":"https://stock-news.laohu8.com/highlight/detail?id=2633182528","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633182528?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:00","pubTimestamp":1778065200,"startTime":"0","endTime":"0","summary":"Immunocore reports first quarter financial results and provides a business update KIMMTRAK (tebentafusp-tebn) Q1 net sales of $106.7 million, growing by 14% year-over-year Oral presentation at AACR: K","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/06/3288641/0/en/Immunocore-reports-first-quarter-financial-results-and-provides-a-business-update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTA","ATOM","BK4211","IE00BFXG0V08.USD","IE00BYQQ9H92.USD","LU2413666699.HKD","PFS","ALT","BK4533","BK4599","BK4585","IND","LU1721428933.USD","IE00B7SZL793.SGD","IE0031619046.USD","BK4195","BK4121","CRS","LU0963586101.USD","LU2211817866.USD","BK4548","LU2413666426.HKD","BK4007","LU1093756325.SGD","BK4147","ORR","BK4567","LU1878469433.USD","LU0347712357.USD","IE00B19Z4B17.USD","BK4207","CM","IE00B5TLWC47.USD","BK4006","BK4588","MTD","LU1093756168.USD","LU2065731478.USD","BK4187","BK4139","IE00B66KJ199.SGD","PROC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633590220","title":"Strategy Shares Down 1.1% Premarket After Co Posts Wider Quarterly Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2633590220","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633590220?lang=en_us&edition=fundamental","pubTime":"2026-05-06 16:08","pubTimestamp":1778054908,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nL4N41J0OG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MST","MSST","XAUUSD.FOREX","IMST","LMI3.UK","BK4585","09399","MSOO","BGLD","MSTY.UK","MSTP","WNTR","MSTW","09799","ROMO","MSII","MTYY","07799","BK4516","MSTY","BK4600","HNDL","BK4588","SMST","FIVR","MSTU","CTA","GOLY","MSDD","APED","MSTK","NZRO","MSTX","SMI3.UK","BK4023","3LMI.UK","BK4595","BK4596","07399","3SMI.UK","MSTZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170431513","title":"Goldman Sachs Warns of Market Pullback Ahead of Tech Giants' Earnings Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=1170431513","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170431513?lang=en_us&edition=fundamental","pubTime":"2026-04-29 09:41","pubTimestamp":1777426883,"startTime":"0","endTime":"0","summary":"A senior executive from Wall Street giant Goldman Sachs, John Flood, has indicated that investors should prepare for a potential short-term pullback in the stock market. This caution comes as equity...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","LU2237443465.HKD","LU2237443978.SGD","LU0345770308.USD","CTA","META","LU1804176565.USD","LU0251131958.USD","GSX","LU0742534661.SGD","LU2471134523.USD","IE0004086264.USD","MSFT","LU2237443895.HKD","LU0251142724.SGD","BK4127","LU2750360997.AUD","LU1868836757.USD","BK4533","GS","LU0106831901.USD","LU1868836591.USD","BK4552","LU1668664300.SGD","LU2471134952.CNY","TSLA","XMAG","BK4588","LU0061475181.USD","IE0004091025.USD","LU2237443382.USD","BK4550","AMZN","LU2237443622.USD","LU2750360641.GBP","NVDA","LU1868836914.USD","LU2471134796.USD","BK4516","LU1894683348.USD","LU2471134879.HKD","LU1791807156.HKD","LU0096364046.USD","LU0048573561.USD","IE00BFXG1179.USD","LU1868837136.USD","IE00BSNM7G36.USD","LU1868837300.USD","IE00B19Z3581.USD","IE0002270589.USD","BK4585","LU1894683264.USD","LU2237443549.SGD","BK4504","LU2237438978.USD","GOOG","LU2265009873.SGD","LU0345770993.USD","AAPL","IE0034235188.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178150909","title":"Oil Price Pressures May Linger Longer Than Expected, Goldman Warns: CTA Ammunition Depleted, Equity Downside Risks Accumulating","url":"https://stock-news.laohu8.com/highlight/detail?id=1178150909","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178150909?lang=en_us&edition=fundamental","pubTime":"2026-04-29 07:38","pubTimestamp":1777419487,"startTime":"0","endTime":"0","summary":"Persistently rising oil prices, combined with geopolitical stalemates, are emitting systemic pressure signals to global financial markets that, while currently ignored by equities, are becoming...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DUG","DRLL","BK4588","BWET","IEO","IXC","DBC","UGA","USL","GUSH","USOI","CTA","USE","DBE","BK4570","OILT","OIH","ERX","DBO","DIG","OILU","BNO","VDE","PXJ","BK4585","DRIP","OILK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630306760","title":"Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2630306760","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630306760?lang=en_us&edition=fundamental","pubTime":"2026-04-28 19:30","pubTimestamp":1777375800,"startTime":"0","endTime":"0","summary":"With recent FDA acceptance of thePhase 2a multidose portion of INLIGHT trial of WVE-007 (INHBE GalNAc-siRNA) in individuals with higher BMI, with and without type 2 diabetes, this portion of the trial","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/28/3282474/0/en/Wave-Life-Sciences-Reports-First-Quarter-2026-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4161","ATS","BK4588","BK4505","RNA","IE0009354923.USD","BK4139","BK4585","CTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629856312","title":"Hisense Memperkenalkan UR9 Series, Mendefinisikan Era Baharu Paparan RGB MiniLED Sebenar","url":"https://stock-news.laohu8.com/highlight/detail?id=2629856312","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629856312?lang=en_us&edition=fundamental","pubTime":"2026-04-23 23:44","pubTimestamp":1776959040,"startTime":"0","endTime":"0","summary":"QINGDAO, China, 23 April 2026 /PRNewswire/ -- Hisense, jenama terkemuka global dalam elektronik pengguna dan peralatan rumah, hari ini mengumumkan pelancaran global barisan televisyen premium terbaharunya, UR9 Series. Lebih daripada sekadar pelancaran produk, UR9 mewakili tafsiran baharu terhadap konsep \"Natural and Real Color\"—bukan sahaja lebih terang, tetapi juga lebih semula jadi, selesa dan sama seperti kehidupan sebenar untuk tontonan harian.Di teras UR9 ialah satu kejayaan dalam cara warna dihasilkan dan dialami. Dengan menjana warna secara langsung pada sumber cahaya, UR9 memberikan tona yang lebih beraneka, perincian lebih tepat serta pengalaman tontonan yang lebih hampir kepada cara mata manusia melihat dunia sebenar—sekali gus mengurangkan keletihan visual sambil meningkatkan tahap imersi.Lonjakan pengalaman berfokuskan pengguna ini dihasilkan dengan teknologi RGB MiniLED termaju milik Hisense. Pada Mac 2026, Lembaga Bahagian Video Persatuan Teknologi Pengguna  telah mengelu","market":"us","thumbnail":"https://mma.prnewswire.com/media/2964110/UR9_16x9_TR.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2964110/UR9_16x9_TR.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/hisense-memperkenalkan-ur9-series-mendefinisikan-era-baharu-paparan-rgb-miniled-sebenar-302752004.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629503499","title":"Enlivex receives CTA approval by DKMA for Phase 2b trial of Allocetra","url":"https://stock-news.laohu8.com/highlight/detail?id=2629503499","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629503499?lang=en_us&edition=fundamental","pubTime":"2026-04-21 20:58","pubTimestamp":1776776295,"startTime":"0","endTime":"0","summary":"Enlivex announced that it has received Clinical Trial Application, CTA, approval by the Danish Medicines Agency, DKMA, for the Phase 2b trial of Al...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/enlivex-receives-cta-approval-by-dkma-for-phase-2b-trial-of-allocetra-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/enlivex-receives-cta-approval-by-dkma-for-phase-2b-trial-of-allocetra-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629023039","title":"Enlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2629023039","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629023039?lang=en_us&edition=fundamental","pubTime":"2026-04-21 20:30","pubTimestamp":1776774600,"startTime":"0","endTime":"0","summary":"· Approval by the Danish Medicines Agency (DKMA) for enrolling patients in Denmark follows the recently announced FDA clearance to initiate the Phase 2b study in the United States. Nes-Ziona, Israel, ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/21/3277942/0/en/Enlivex-Announces-Second-Regulatory-Approval-for-Phase-2b-Trial-of-Allocetra-in-Age-Related-Primary-Moderate-to-Severe-Knee-Osteoarthritis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":86,"code":"91000000","status":"200"}]}}